189 related articles for article (PubMed ID: 11232776)
1. Determination of the antibacterial efficacy of several antiseptics tested on skin by an 'ex-vivo' test.
Messager S; Goddard PA; Dettmar PW; Maillard JY
J Med Microbiol; 2001 Mar; 50(3):284-292. PubMed ID: 11232776
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial efficacy of biocides tested on skin using an ex-vivo test.
Maillard JY; Messager S; Veillon R
J Hosp Infect; 1998 Dec; 40(4):313-23. PubMed ID: 9868624
[TBL] [Abstract][Full Text] [Related]
3. Use of the 'ex vivo' test to study long-term bacterial survival on human skin and their sensitivity to antisepsis.
Messager S; Hann AC; Goddard PA; Dettmar PW; Maillard JY
J Appl Microbiol; 2004; 97(6):1149-60. PubMed ID: 15546405
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of fast-acting bactericidal activity and substantivity of an antiseptic agent, olanexidine gluconate, using an ex vivo skin model.
Nishioka H; Nagahama A; Inoue Y; Hagi A
J Med Microbiol; 2018 Dec; 67(12):1796-1803. PubMed ID: 30403371
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two in vivo and two ex vivo tests to assess the antibacterial activity of several antiseptics.
Messager S; Goddard PA; Dettmar PW; Maillard JY
J Hosp Infect; 2004 Oct; 58(2):115-21. PubMed ID: 15474182
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of chlorhexidine and povidone iodine activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis using a surface test.
Block C; Robenshtok E; Simhon A; Shapiro M
J Hosp Infect; 2000 Oct; 46(2):147-52. PubMed ID: 11049709
[TBL] [Abstract][Full Text] [Related]
7. Antiseptic Efficacy of Povidone Iodine and Chlorhexidine Gluconate Skin Preparation Solutions Used in Burns Surgery.
Smock E; Demertzi E; Abdolrasouli A; Azadian B; Williams G
J Burn Care Res; 2018 Apr; 39(3):440-444. PubMed ID: 29897541
[TBL] [Abstract][Full Text] [Related]
8. Standardized comparison of antiseptic efficacy of triclosan, PVP-iodine, octenidine dihydrochloride, polyhexanide and chlorhexidine digluconate.
Koburger T; Hübner NO; Braun M; Siebert J; Kramer A
J Antimicrob Chemother; 2010 Aug; 65(8):1712-9. PubMed ID: 20551215
[TBL] [Abstract][Full Text] [Related]
9. Proposed phase 2/ step 2 in-vitro test on basis of EN 14561 for standardised testing of the wound antiseptics PVP-iodine, chlorhexidine digluconate, polihexanide and octenidine dihydrochloride.
Schedler K; Assadian O; Brautferger U; Müller G; Koburger T; Classen S; Kramer A
BMC Infect Dis; 2017 Feb; 17(1):143. PubMed ID: 28193164
[TBL] [Abstract][Full Text] [Related]
10. Novel antiseptic compound OPB-2045G shows potent bactericidal activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus both in vitro and in vivo: a pilot study in animals.
Inoue Y; Hagi A; Nii T; Tsubotani Y; Nakata H; Iwata K
J Med Microbiol; 2015 Jan; 64(Pt 1):32-36. PubMed ID: 25351713
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the antibacterial activity of tea tree oil using the European EN 1276 and EN 12054 standard suspension tests.
Messager S; Hammer KA; Carson CF; Riley TV
J Hosp Infect; 2005 Feb; 59(2):113-25. PubMed ID: 15620445
[TBL] [Abstract][Full Text] [Related]
12. Effects of olanexidine gluconate on preoperative skin preparation: an experimental study in cynomolgus monkeys.
Nakata H; Tsubotani Y; Nii T; Hagi A; Inoue Y; Imamura T
J Med Microbiol; 2017 May; 66(5):678-685. PubMed ID: 28516852
[TBL] [Abstract][Full Text] [Related]
13. Comparative susceptibility of resident and transient hand bacteria to para-chloro-meta-xylenol and triclosan.
Johnson SA; Goddard PA; Iliffe C; Timmins B; Rickard AH; Robson G; Handley PS
J Appl Microbiol; 2002; 93(2):336-44. PubMed ID: 12147083
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo porcine vaginal mucosal model of infection for determining effectiveness and toxicity of antiseptics.
Anderson MJ; Scholz MT; Parks PJ; Peterson ML
J Appl Microbiol; 2013 Sep; 115(3):679-88. PubMed ID: 23773892
[TBL] [Abstract][Full Text] [Related]
15. Bactericidal activity of 3 cutaneous/mucosal antiseptic solutions in the presence of interfering substances: Improvement of the NF EN 13727 European Standard?
Salvatico S; Feuillolay C; Mas Y; Verrière F; Roques C
Med Mal Infect; 2015 Mar; 45(3):89-94. PubMed ID: 25779009
[TBL] [Abstract][Full Text] [Related]
16. Sustained ex vivo skin antiseptic activity of chlorhexidine in poly(epsilon-caprolactone) nanocapsule encapsulated form and as a digluconate.
Lboutounne H; Chaulet JF; Ploton C; Falson F; Pirot F
J Control Release; 2002 Aug; 82(2-3):319-34. PubMed ID: 12175746
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of five protocols for surgical handwashing in relation to skin condition and microbial counts.
Pereira LJ; Lee GM; Wade KJ
J Hosp Infect; 1997 May; 36(1):49-65. PubMed ID: 9172045
[TBL] [Abstract][Full Text] [Related]
18. Skin asepsis protocols as a preventive measure of surgical site infections in dogs: chlorhexidine-alcohol versus povidone-iodine.
Belo L; Serrano I; Cunha E; Carneiro C; Tavares L; Miguel Carreira L; Oliveira M
BMC Vet Res; 2018 Mar; 14(1):95. PubMed ID: 29540169
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial efficacy of a very stable hypochlorous acid formula compared with other antiseptics used in treating wounds: in-vitro study on micro-organisms with or without biofilm.
Herruzo R; Herruzo I
J Hosp Infect; 2020 Jun; 105(2):289-294. PubMed ID: 31987843
[TBL] [Abstract][Full Text] [Related]
20. The antibacterial activity of topical retinoids: the case of retinaldehyde.
Pechère M; Germanier L; Siegenthaler G; Pechère JC; Saurat JH
Dermatology; 2002; 205(2):153-8. PubMed ID: 12218231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
